TOFEZV-ER is an advanced therapeutic formulation containing Tofacitinib in an Extended Release (ER) format, specifically engineered to provide a controlled and sustained delivery of the medication over a 24-hour period. As a potent Janus Kinase (JAK) inhibitor, it is highly effective in managing chronic inflammatory conditions such as rheumatoid arthritis and psoriatic arthritis by consistently modulating the body's immune response.
TOFEZV-ER
Composition:
Tofacitinib IP 11mg
Packing:
10 X 10